Nutrasource Blog

The Importance of Investigational New Drug (IND) Applications and Clinical Trial Applications (CTAs) for Drug Development Strategy

New Approach Methods in Toxicology: Innovations in In Vitro Testing for Chemical Safety

Marketing Claims for Natural Health Products in Canada

Master Files: What Are They and When to Use Them

VHPs in Canada: A Growing Market with a Regulated Pathway

Unlocking the Benefits: A Step-by-Step IFOS™ Certification Guide for Korean Manufactured Omega-3 Supplements

Consumers Fact Check Their Products, Do You Have What They Are Looking For?

Food Regulation in Canada

Decentralized Clinical Trials: What you need to know about remote studies

What We Saw in 2022: Key Trends

How to Not Get Kicked Off for Non-Compliant Natural Health Products

What you need to know about drug submissions

The “Do’s and Don’ts” of Claims Substantiation for Dietary Supplements and Natural Health Products

New Labelling Requirements for Natural Health Products

FDA Announces New Policy for New Dietary Ingredient Notifications (NDINS) - An Ingredient Manufacturer Must Read!

Food vs. Dietary Supplement / NHP vs. Drug in Canada and US

Non-GMO Testing and Certification: It doesn't have to be complicated

Product Classification: A Starting Point for Your Regulatory Strategy

GRAS or NDIN: Which is the Right Regulatory Strategy for My Ingredient?

Concept to Claim: An abbreviated guide for dietary supplement brands

The Latest in Food Allergen Labelling: Sesame

Team Talk: Meet Anna Metcalfe, RAC, VP, Pharmaceutical Sciences

How to Develop Cutting-Edge (and Compliant) Dietary Supplements

The State of Sport Nutrition: a peek into the multi-billion dollar industry

NDIN’s and Structure Function Claims in the Time of COVID-19

Clinical Trial Research Solutions During Social Isolation

Navigating Medical Foods in the U.S. and EU

How to Validate Your Products Through Clinical Research

Postbiotics: What Are They and How Do They Fit Into the Health Product Industry

Common Stability Testing Questions for Natural Health Products (Canada) and Dietary Supplements (U.S.)

Team Talk: Sandra Dudziak, Nurse Practitioner PhD, MSc., BScN.

Oh Cannabis: Navigating the New Regulations for Cannabis Edibles in Canada

The Continued Rise of Probiotics: A Q&A With George Paraskevakos

Team Talk: Meet Rob Greco, Clinical Trial Coordinator

Top 3 Reasons to Conduct Clinical Research in Canada

The 3 Requirements for Selling a Natural Health Product in Canada

A Regulatory Recipe for Adding Prebiotics and Novel Strains to Your Probiotic Line

Seeing Clearly: Using Transparency to Regain Trust in the Supplement Industry

Your (Canadian) CBD Questions Answered

Team Talk: Meet Dr. Susan J. Hewlings, Director of Scientific Affairs

Go to Market in Multiple Countries with One Product Spec

Team Talk: Meet Katie Keene, Clinical Research Coordinator

Ready to Comply with New Supplement and Nutrition Labels by 2022?

The Supplement Industry Still Has a Claims Substantiation Problem. Here's How to Fix It

Regulatory Trends That Will Shape 2019

Shotgun Metagenomics: A Viable Solution for Species Identification of Supplements and Foods?

Supplement and Weight Loss Strategies to Help Active Consumers Stay Lean and Fit

How to Form a CRO Partnership That Delivers Results

Prop 65 Updates: How to Ensure Dietary Supplement Compliance in California

Substantiating Products With No Guidance: The CBD Confusion

Implications of FDA's GRAS and NDIN Policy Changes for Supplements and Medical Foods

Next Steps for Commercializing Medical Cannabis Products in Canada, the U.S., and Beyond

Reverse-Engineering Your Regulatory Strategy for More Efficient Product Development

How Health Canada’s Upcoming Self-Care Product Regulations Could Impact Your Marketed Natural Health Products, Non-Prescription Drugs, and Cosmetics

Can DNA Testing Solve the Supplement Industry’s Identity Problems?

What to Expect When Conducting Dietary Supplement Clinical Trials

Nutrasource, GOED, DSM Jointly Publish Largest-Ever Fish Oil Oxidation Study

Let's Connect at 2018's Most Buzzworthy Natural Health Events

Understanding the Clinical Trials Pathway for Probiotics

The Future of Probiotics from the International Probiotics Association

Planning for Risk Mitigation Is Key to a Successful Clinical Research Strategy

Managing Risk in Probiotic Stability

Setting Higher Quality Standards for Label Claims

Demystifying Clinical Study Designs for Probiotics

The Future of Probiotics is Bright: Q&A with International Probiotics Association's George Paraskevakos

What to Look for in a Dietary Supplement CRO

5 Essential Tips for Substantiating Dietary Supplement Claims

Taking an Integrated Clinical and Regulatory Approach for the Prebiotic/Probiotic Market

Understanding the Differences Between Phase I, II, III, and IV Clinical Trials

Start with the Product Claim When Developing a Dietary Supplement

Is Your Dietary Supplement Commercialization Plan on Target?

The 5 Key Questions to Ask Before Your Next Product Launch

Benefits of Conducting Clinical Research in Canada

An Introduction to Generally Recognized as Safe (GRAS) Filings for Food Ingredients

Health Claims That Can Get You in Hot Water

Your Top Regulatory, R&D, and Testing Questions Answered

Can Your Dietary Supplement Claims Stand Up to the FTC?

How to Choose an Analytical Testing Lab for Dietary Supplements

Top 10 Stability Storage and Testing FAQs

The Value of Third-Party Certifications for the Natural Health Industry

5 Questions to Ask When Navigating the Regulatory Pathway